HCA Healthcare, Inc. $HCA Stock Holdings Reduced by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,475 shares of the company’s stock after selling 1,362 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in HCA Healthcare were worth $10,005,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Ameriflex Group Inc. acquired a new position in HCA Healthcare during the second quarter worth $27,000. Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare in the 2nd quarter valued at approximately $27,000. Clearstead Trust LLC boosted its position in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. Harbor Capital Advisors Inc. lifted its stake in shares of HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after buying an additional 34 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at $40,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 1.2%

HCA opened at $488.19 on Friday. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $527.55. The stock has a market cap of $111.40 billion, a P/E ratio of 17.20, a P/E/G ratio of 1.48 and a beta of 1.36. The company has a fifty day simple moving average of $481.07 and a 200 day simple moving average of $437.35.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.HCA Healthcare’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio is 10.15%.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Strong quarterly results and market reaction — HCA reported an EPS beat and raised FY 2026 guidance, prompting coverage noting a gap up in the stock after the print. Shares Gap Up on Strong Earnings
• Positive Sentiment: Analysts boost targets and maintain bullish ratings — Goldman Sachs raised its price target to $558 (buy) and Leerink Partners increased its target to $573 (outperform), supporting further upside potential. Goldman Sachs Raises PT Leerink Raises PT TickerReport
• Positive Sentiment: Additional bullish analyst commentary — Truist and Deutsche Bank analysts publicly stated expectations for HCA shares to rise, reinforcing the buy-side momentum. Truist Note Deutsche Bank Note
• Positive Sentiment: Brand and quality recognition — Multiple HCA hospitals placed on Healthgrades’ America’s 50/100/250 Best Hospitals lists, supporting reputation and referral flows. Healthgrades Recognition
• Positive Sentiment: Outpatient growth and M&A runway — Company commentary and industry pieces highlight HCA’s push into outpatient facilities and acquisition opportunities, which investors view as margin‑accretive growth. Outpatient Growth Acquisition Opportunities
• Positive Sentiment: Bullish research notes/coverage — Zacks highlights HCA as a strong growth stock based on style scores, adding to favorable retail/institutional sentiment. Zacks Growth Stock Piece
• Neutral Sentiment: Analysts say the narrative is shifting — Coverage explores how the investment story is evolving post‑earnings/target resets; watch valuation vs. growth expectations. Analyst Narrative
• Neutral Sentiment: Local expansion and competitive landscape — Reporting on new ER builds and regional facility activity (e.g., southwest Florida) that may influence local market share dynamics. Local ER Story Freestanding EDs
• Negative Sentiment: Policy/regulatory risk — HCA is publicly noting it is monitoring federal policy shifts that could affect reimbursement or operations; this is a watcher for downside risk. Policy Risk

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. KeyCorp set a $503.00 target price on HCA Healthcare in a research note on Wednesday. Zacks Research downgraded HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Stephens increased their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday. Finally, The Goldman Sachs Group upped their target price on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday. Fifteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $518.76.

Insider Buying and Selling

In related news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.